A new review pulls the whole picture together. SARS-CoV-2 doesn’t just infect. It disrupts immunity at multiple levels - from interferons to inflammasomes to deep T-cell exhaustion.
If you still think COVID is just a respiratory virus, this paper will change your mind🧵. @DavidJoffe64
The study shows why severe COVID and Long COVID share the same roots - mis-timed immunity, destructive inflammation, and exhausted T cells that struggle to clear antigen or build lasting protection.
It’s now well-documented.
Current evidence - from interferon suppression to inflammasome activation to T-cell exhaustion - fits into one coherent biological picture.
Step One. The virus shuts down the interferon response.
SARS-CoV-2 is exceptionally effective at suppressing type I interferons.
This creates two immediate consequences
The virus replicates freely during the first days - very high viral load.
The immune system responds late and overreacts - foundation for severe disease.
This timing defect is one of the core reasons COVID-19 can escalate so quickly.
Step Two: Inflammasome activation and pyroptosis
Once interferons are blunted, a domino effect begins.
The virus strongly activates the NLRP3 inflammasome, producing IL-1β and IL-18 and triggering pyroptosis - a highly inflammatory form of programmed cell death.
The result.
Massive local and systemic inflammation,
lung and endothelial injury,
DAMP release that further amplifies immune activation.
This mechanistic cascade explains ARDS, vascular inflammation, even MIS-C.
Step 3. The immune system loses control - dysregulated circuits.
COVID-19 immunopathology is not caused by too strong immunity, but by mistimed immunity.
NK and T cells become dysfunctional and depleted,
regulatory feedback loops fail,
inflammatory pathways run unchecked while antiviral pathways collapse.
The biology resembles a system pressing the accelerator and the brake at the same time.
The major axis - T-cell exhaustion.
The newer literature adds a crucial and often overlooked dimension.
SARS-CoV-2 rapidly induces T-cell exhaustion, a profile typically associated with chronic infections like HIV, HBV, or HCV.
High expression of PD-1, TIM-3, LAG-3,
reduced IFN-γ, IL-2, TNF-α,
impaired proliferation and cytotoxicity,
transcriptional rewiring via TOX and NR4A,
metabolic stress (ROS, mitochondrial dysfunction),
epigenetic locking (H3K27me3, DNA hypermethylation).
This is remarkable - an acute virus induces exhaustion programs seen in chronic infections.
Clinical impact = worse acute outcomes and slower viral clearance
Exhausted T cells = reduced ability to eliminate infected cells.
This strongly correlates with
higher mortality,
prolonged illness,
delayed viral clearance,
greater tissue damage.
In mild disease, exhaustion can be transient - but in severe cases it becomes persistent.
Long COVID as a state of persistent immunological dysregulation.
T-cell exhaustion leaves lasting scars
expanded PD-1 TOX CD8+ T cells for months,
reduced IL-2 and impaired proliferation,
weakened memory T-cell responses,
more frequent EBV/CMV reactivation,
increased vulnerability to opportunistic infections.
This forms a feed-forward loop.
Persistent antigen - exhausted T cells - impaired clearance - persistent symptoms.
This maps directly onto clinical features of Long COVID - fatigue, brain fog, dysautonomia, chronic inflammation, reduced vaccine response, impaired protection against reinfection.
The full picture = SARS-CoV-2 disrupts innate and adaptive immunity simultaneously.
The virus mounts a triple hit
Suppresses early antiviral defense (interferons),
Triggers destructive inflammasome pathways and pyroptosis,
Exhausts adaptive immunity and epigenetically rewires T-cell programs.
By knocking out interferons, driving inflammasome injury, and exhausting T cells, SARS-CoV-2 creates an environment where acute disease is more severe, viral clearance is slower, and long-term sequelae are more likely.
Sum:
SARS-CoV-2 disrupts immunity on multiple fronts at once - it suppresses early defenses, triggers destructive inflammation, and epigenetically exhausts T cells. This combination explains the severe acute disease, the slow recovery, and the long-lasting post-infectious consequences observed in millions of people.
Roderick Chen‑Camaño et al., Frontiers in Immunology 2025. T‑cell exhaustion in COVID‑19: what do we know? @szupraha @ZdravkoOnline @adamvojtech86 frontiersin.org/journals/immun…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This new Nature Communications study is the most comprehensive look we’ve ever had at SARS-CoV-2 inside the human fetus.
And the message is straightforward.
Vertical transmission is real,
and the virus can reach multiple fetal organs - even early in pregnancy🧵
For years we heard that fetal infection was rare.
But that was based on limited testing, often using low-sensitivity methods.
When you apply ddPCR, subgenomic RNA, RNAscope, immunofluorescence and TEM, a different picture appears.
The virus can infect the fetus - and more often than previously recognized.
Three years after infection, the virus still leaves a fingerprint. The damage is clear - profound mitochondrial dysfunction in CD56bright NK and CD4 T cells - a problem that only appears when the immune system is pushed to respond.🧵
This study makes one thing very clear.
Long COVID isn’t just a cluster of lingering symptoms - it reflects a measurable biological state, marked by weakened antiviral immunity and impaired cellular energy metabolism
The researchers found a striking problem in two key immune cell types.
This study does more than show that SARS-CoV-2 can enter neurons. It reveals a specific and biologically meaningful mechanism by which the virus can damage the exact brain cells whose degeneration leads to Parkinson’s disease🧵
The virus doesn’t infect neurons randomly - it targets A9 dopaminergic neurons.
These are the neurons in the substantia nigra that die first and fastest in Parkinson’s disease.
The study shows that SARS-CoV-2 infects exactly this subtype, because they express ACE2 and allow viral entry.
A10 neurons and cortical neurons?
Not infected.
This selective vulnerability alone forms a credible biological pathway from a virus to parkinsonian symptoms.
A new metabolomic study does something important. It looks directly at the biochemical products circulating in plasma - a real-time readout of how cells are functioning. And the results are clear - even clinically recovered individuals show measurable metabolic and proteomic deviations from uninfected controls.🧵
The main finding is unmistakable. A systemic collapse of mitochondrial energy metabolism. TCA cycle intermediates down, NAD cycling disrupted, oxidative phosphorylation impaired. These biochemical changes map onto the symptoms frequently reported in long COVID (fatigue, PEM, cognitive dysfunction).
The study also shows major shifts in arginine metabolism (impacting NO, vascular function, autonomic stability) and lipid pathways (arachidonate, inflammatory mediators). Together, these explain POTS-like symptoms, pain, migraines, and microcirculatory issues.
New data shows that 3-4 years after infection, people still carry highly cytotoxic spike-specific CD4+ T cells - the kind of long-lasting elite clones usually seen in persistent infections like CMV or HIV🧵
This isn’t a typical post respiratory virus immune profile.
And it tells us something important - the immune system has been pushed into a long-term, selective state that goes far beyond what we expect from an acute infection.
The key finding is simple but profound - even after 3-4 years, people retain spike-specific CD4+ T cells that are highly cytotoxic, transcriptionally active, and clonally stable.
A new study may finally explain how EBV triggers and worsen lupus.
A paper in Science Translational Medicine + Stanford Medicine report just clarified a question researchers have chased for decades.
How can a virus that almost everyone carries ignite lupus in some people?🧵
Lupus (SLE) doesn’t just appear.
You need the right (or wrong) genetics, a breakdown in immune control, and a trigger.
This new study points to Epstein–Barr virus (EBV) as that trigger - possibly in most lupus cases.
Almost all adults carry EBV for life.
The difference between healthy people and lupus patients isn’t whether they have the virus -
but which cells it infects and how it changes them.